Microphage Inc. Names Mel Schatz to Board of Directors

Published: Oct 01, 2010

LONGMONT, Colo.--(BUSINESS WIRE)--MicroPhage, Inc. announced today that Mel Schatz has been named to the company’s board of directors. Mr. Schatz is an experienced industry executive and has held senior leadership positions at Abbott Diagnostics, Medtronic, Bacchus Vascular and is the current President and CEO of at Crux Biomedical.

Back to news